The digital therapeutics market is gaining traction worldwide, earning USD 4.68 billion in 2024 and projected to reach USD 10.09 billion by 2029. This rapid growth looks set to revolutionise healthcare, offering exciting possibilities for non-invasive, evidence-based, cost-effective, and personalised solutions for various health issues.
Singapore is the first country in Southeast Asia to rank high in the top five globally—second and first, respectively—for revenue generated and user penetration. Its therapeutics market will grow annually by 1,770.25% as people seek convenient, accessible, preventative, and self-managing care. Throughout the region, robust governmental healthcare regulations and initiatives are helping power the sector.
We explore how Singapore is embracing artificial intelligence in healthcare
Examples of emerging digital therapies in the Association of Southeast Asian Nations (ASEAN) include mobile health apps, software-based treatments, and digital behavioural health platforms. Key sectoral players include femtech companies like the Clue App and Flo Health for tracking menstrual wellness, and startups like MiyaHealth, which uses artificial intelligence (AI) to improve patient care.
Digital therapeutics adoption in the region
The burden of chronic diseases like diabetes is overwhelming societies and the healthcare system worldwide. Nevertheless, the technology can intervene at multiple points in the patient’s journey—from disease monitoring, medication alerts, gamified behavioural modification, risk predictions, and coaching to real-time personalised health recommendations. Furthermore, everyone can join communities to discuss ideas for better managing specific illnesses.
Several factors and initiatives power digital therapeutics adoption in ASEAN:
Expanding access to treatment
After the COVID-19 pandemic hit the region, it became essential for patients from various backgrounds to consult with a doctor and receive medication. Remote communication technologies like Zoom enabled telemedicine to become a viable consultation method. Thus, anyone seeking treatment, even from rural areas, could speak with a qualified medical practitioner to alleviate their problems. It also became possible to monitor diseases remotely through digital implants.
Reduced treatment costs
Technology is a game-changer when it comes to healthcare costs. By providing convenient and efficient methods for tracking vital signs, such as heart rates, stress, and sleep patterns, it’s helping to lower treatment costs. Patients no longer have to undergo expensive tests to know how their bodies are functioning, and low-income earners can avoid having to pay for consultations or booking laboratory tests since their medical information is readily available. This reassures us that healthcare can be affordable for all.
Enhancing patient adherence
Some patients struggle to keep track of their medication schedules and often end up either failing to take pills at the right time or using more than the prescribed amount to cover a missed period. This misuse of the medication leads to overdoses or patients developing immunity to their drugs, thereby requiring the doctors to prepare a new treatment approach.
Technology takes this stress away by storing the schedules and notifying the patients when they should take the pills. Additionally, it provides details of the ideal amounts to ensure the patients are always aware of what medication they need to take and how much.
Medical innovation
ASEAN has a creative, tech-savvy population that can innovate quality products and services. For example, disruptive technologies like Electronic Health Records (EHRs) give doctors and pharmacists instant access to patient information to help remove medical error risks and improve patient outcomes.
Regulatory support and directives
With the nascent health technology market becoming a reality, the region’s governments provide guidance and support for the ecosystem by regulating digital health services. Two essential examples for protecting patient data include the Regulatory Guideline for Telehealth Products in Singapore and Thailand’s Guideline on Telemedicine and Online Clinics.
Industry collaboration
Collaboration among healthtech stakeholders keeps tech startups, pharmaceutical companies, healthcare providers, and regulatory bodies on the same page in developing the ecosystem. For example, Medisix Therapeutics, an industry leader in immune engineering addressing T-cell malignancies, teamed up with SGInnovate to organise a biotech event for discussions and insights on what it takes to succeed in the industry.
Challenges and future impact on ASEAN’s healthcare landscape
The future of ASEAN’s healthcare landscape holds promise as the region’s digital transformation spreads, particularly in managing chronic diseases and mental health issues.
Significant challenges undermining the sector include fragmented regulatory barriers among regional governments, data security concerns, non-inclusive solutions, and the need for public trust, clinical validation, and physician acceptance. Moreover, there is occasional friction when using the technologies, and some people need to be made aware of the healthtech benefits available.
Ultimately, the prevalence of chronic conditions means Southeast Asia must innovate more solutions to improve patient outcomes and experiences. They must also seek investments, adopt technologies like blockchain, and emphasise providing value-based care and data-driven health products and services that complement traditional medical treatments.
Governments must address the healthcare regulation needs requested by stakeholders for the ecosystem to run efficiently. Leaders must also close the tech divide so people in rural areas can access digital therapeutics. Additionally, addressing pollution and climate change issues that worsen health conditions can reduce the burden on the medical system.